WESTLAKE, Ohio, Sept. 15 /PRNewswire/ -- Radiometer has announced the U.S. commercial release of its ABL80 FLEX CO-OX, a portable blood gas analyzer that brings Radiometer’s trusted CO-oximetry technology to the point of care.
The ABL80 FLEX CO-OX matches the CO-oximetry performance of Radiometer’s benchtop analyzers, representing Radiometer’s commitment to providing quality solutions for both laboratory and point-of-care testing. In addition to CO-oximetry, the ABL80 FLEX CO-OX accurately measures pH, blood gases, electrolytes and glucose parameters.
Radiometer’s sophisticated CO-oximetry technology utilizes multi-wavelength technology for high measurement performance combined with an ultrasonic hemolyzation process. Ultrasonic hemolyzation offers advantages over chemical hemolyzation, including low maintenance and zero risk of interference from chemical hemolyzing agents or partially hemolyzed red blood cells.
About Radiometer
Radiometer is a world leader in the development, manufacture and distribution of technologically advanced acute care testing solutions. Radiometer’s products and services simplify and automate all phases of acute care testing, so hospitals can get fast results, reduce workload and the risk of errors, and improve cost effectiveness. For more information, visit www.radiometeramerica.com .
CONTACT: Jan Weaver, Marketing Services Manager of Radiometer America
Inc., +1-440-871-8900, ext. 262, jweaver@radiometeramerica.com
Web site: http://www.radiometeramerica.com/
